• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APIFIX LTD. MID-C 125; POSTERIOR RATCHETING ROD SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APIFIX LTD. MID-C 125; POSTERIOR RATCHETING ROD SYSTEM Back to Search Results
Model Number MID-C 125
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Wound Dehiscence (1154)
Event Date 09/19/2023
Event Type  Injury  
Manufacturer Narrative
A review of the device history record confirmed that the device was manufactured and tested according to relevant procedures, and shipped according to manufacturer's specifications.Patient #(b)(6) index procedure was performed on (b)(6) 2022.Patient #(b)(6)underwent removal surgery on (b)(6) 2023 following screw breakage and 1 month in a corset brace (ref: (b)(4)).On (b)(6) 2023, during monitoring as part of the pas study, apifix was made aware that patient #(b)(6)) reportedly had wound dehiscence following the (b)(6) 2023 removal.Dehiscence was classified as 'mild', 1-1.5cm wound dehiscence distally without any evidence of active infection.Patient was treated (outpatient) with wet to dry wound dressings.As of (b)(6) 2023, issue had reportedly been resolved with no further treatment required.Apifix believes that dressing and local wound care may qualify as medical treatment to prevent a more aggressive intervention, especially as wound dehiscence is a common way that later-term wound infections often become apparent, and in an abundance of caution, apifix is reporting this event.Risk assessment: early infections (e.G, wound complications) are usually surgery related and resolve without sequala following conservative treatment.The risk of wound dehiscence is a known risk.This risk has been assessed and found to be acceptable per the company cer.The event of wound dehiscence is addressed in the ifu in the 'potential risks associated with the mid-c system and spinal surgery generally' section.Apifix is closing this complaint, but will continue to monitor this 'failure mode'; complaint trending will continue to monitor per post marketing surveillance procedure.If any further relevant information is identified, the complaint file will be reopened and a supplemental medwatch will be filed.
 
Event Description
Apifix was made aware that patient #(b)(6) reportedly had wound dehiscence following their implant removal.Patient was treated (outpatient) with wet to dry wound dressings.Issue had reportedly been resolved as of (b)(6) 2023.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MID-C 125
Type of Device
POSTERIOR RATCHETING ROD SYSTEM
Manufacturer (Section D)
APIFIX LTD.
1 hacarmel st.
yokneam ellit, 20692 07
IS  2069207
Manufacturer (Section G)
APIFIX LTD.
1 hacarmel st.
yokneam ellit, 20692 07
IS   2069207
Manufacturer Contact
alan vaisman
1 hacarmel st.
yokneam ellit, 20692-07
IS   2069207
MDR Report Key18208048
MDR Text Key328959459
Report Number3013461531-2023-00056
Device Sequence Number1
Product Code QGP
UDI-Device Identifier07290018128046
UDI-Public07290018128046
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
H170001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other
Reporter Occupation Other
Type of Report Initial
Report Date 11/27/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/27/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Model NumberMID-C 125
Device Catalogue NumberMUS-125-050
Device Lot NumberAF-03-080-21
Date Manufacturer Received11/03/2023
Date Device Manufactured05/06/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age17 YR
Patient SexFemale
-
-